Literature DB >> 19324985

Very late delayed-allergic reaction to natalizumab not associated with neutralizing antibodies.

J Killestein, B Jasperse, M Liedorp, A Seewann, Ch Polman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19324985     DOI: 10.1177/1352458508101322

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  3 in total

Review 1.  Antidrug Antibodies Against Biological Treatments for Multiple Sclerosis.

Authors:  Per Soelberg Sorensen
Journal:  CNS Drugs       Date:  2022-05-19       Impact factor: 6.497

2.  Cutaneous Adverse Reactions Associated with Monoclonal Antibodies Treatment in Multiple Sclerosis: Case Reports and Short Literature Review.

Authors:  Carmen Adella Sirbu; Raluca Ivan; Titus Mihai Vasile; Lucian George Eftimie; Daniel Octavian Costache
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

3.  Natalizumab in the treatment of multiple sclerosis.

Authors:  Brandon A Brown
Journal:  Ther Clin Risk Manag       Date:  2009-08-03       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.